Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
16,49 USD | +8,42 % | +7,85 % | +141,79 % |
Resumen de negocios
Número de empleados: 100
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Antibody-based Therapeutic Products
100,0
%
| 49 | 100,0 % | 84 | 100,0 % | +71,15 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
80,4
%
| 46 | 93,9 % | 68 | 80,4 % | +46,60 % |
Other Countries
19,6
%
| 3 | 6,1 % | 17 | 19,6 % | +448,70 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Thomas Gad
FOU | Founder | 54 | 01/04/15 |
Michael Rossi
CEO | Chief Executive Officer | 53 | 06/11 |
Bo Kruse
DFI | Director of Finance/CFO | 52 | 01/06/16 |
Vignesh Rajah
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/06/20 |
Joris Wilms
COO | Chief Operating Officer | 50 | 01/11/17 |
Chief Tech/Sci/R&D Officer | 73 | 01/01/16 | |
Sue Smith
PRN | Corporate Officer/Principal | 54 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
David Gill
BRD | Director/Board Member | 69 | 01/12/17 |
Director/Board Member | 54 | 01/09/15 | |
James Healy
CHM | Chairman | 58 | 01/11/17 |
Ashutosh Tyagi
BRD | Director/Board Member | 47 | 01/11/17 |
Bo Kruse
DFI | Director of Finance/CFO | 52 | 01/06/16 |
Gérard Ber
BRD | Director/Board Member | 66 | 11/12/18 |
Michael Rossi
CEO | Chief Executive Officer | 53 | 06/11 |
Thomas Gad
FOU | Founder | 54 | 01/04/15 |
Laura Hamill
BRD | Director/Board Member | 60 | 01/04/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 43 777 105 | 37 409 819 ( 85,46 %) | 0 | 85,46 % |
Información de la empresa
Sector
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+141,79 % | 723 M | |
-1,17 % | 104 mil M | |
+2,87 % | 97,47 mil M | |
+3,84 % | 22,25 mil M | |
-14,77 % | 21,68 mil M | |
-8,54 % | 18,2 mil M | |
-39,98 % | 17,02 mil M | |
-13,21 % | 16,36 mil M | |
+8,55 % | 14,39 mil M | |
+35,75 % | 12,37 mil M |
- Bolsa de valores
- Acciones
- Acción YMAB
- Empresa Y-mAbs Therapeutics, Inc.